Opioid pills In the matter of musculoskeletal issues, researchers point to an increased reliance on opioids for pain management, which increases overall costs but offers little overall improvement in quality of life.

As the high cost of health care remains a top financial stressor for many Americans, consumers must struggle with the question of whether a particular medical service is worth the price. IT's becoming an even more pressing question as new innovations come to market, including million-dollar cancer drugs and costly gene therapies.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Emily Payne

Emily Payne is director, content analytics for ALM's Business & Finance Markets and former managing editor for BenefitsPRO. A Wisconsin native, she has spent the past decade writing and editing for various athletic and fitness publications. She holds an English degree and Business certificate from the University of Wisconsin.

Graphic by Chelsey Fredlund